1. Canada Stocks

  2. •

    Health technology

  3. •

    Pharmaceuticals: generic
HYDROGEN HYBRID TECHNOLOGIES INC

HYDROGEN HYBRID TECHNOLOGIES INC

OOTC:HYHY
0.00
USD
+0.00
(+9,900.00%)
-0.04EPS
2.81MMarket Cap
HYDROGEN HYBRID TECHNOLOGIES INC
OTC:HYHY
(OTC Markets)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2005
2006
2007
2008
TTM
USD
- -
- -
- -
- -
- -
Revenue per Share
- -
- -
-0.01
-0.03
-0.04
Basic EPS, GAAP
- -
- -
-0.04
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
0.05
0.01
0.01
Book Value per Share
- -
- -
-0.01
-0.02
-0.01
Tangible Book Value per Share
22
22
80
109
95
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
-942.89
-1,051.72
-1,119.54
Operating Margin (%)
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
-1
-3
-3
Net Income, GAAP
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
-942.89
-1,085.21
-1,168.14
Profit Margin (%)
- -
- -
-1
-1
-1
Working Capital
- -
- -
- -
- -
- -
LT Debt
- -
- -
4
1
1
Total Equity
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
-122.67
-138.65
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Sep'08
Dec'09
Mar'09
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
89
89
94
Market Capitalization
44
4
3

Working Capital

USD

•

in mil. unless spec.
Sep'08
Dec'09
Mar'09
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-78.47%
Free Cash Flow
- -
- -
-105.04%
Net Income, GAAP
- -
- -
177.36%
Sales/Revenue/Turnover
- -
- -
140.98%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -
2009
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2007
- -
- -
-0.01
- -
-0.01
2008
- -
- -
- -
-0.04
-0.03
2009
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -
2009
- -
- -
- -
- -
- -
Similar Companies
Teva Pharmaceutical Industries Limited (NYSE:TEVA)
Teva Pharmaceutical Industries Limited (TASE:TEVA)
Jagsonpal Pharmaceuticals Ltd. (NSE:JAGSNPHARM)
Zim Laboratories Ltd. (NSE:ZIMLAB)
Paradigm Biopharmaceuticals Ltd. (ASX:PAR)
Neuren Pharmaceuticals Limited (ASX:NEU)
Business
Hydrogen Hybrid Technologies, Inc. (HYHY) manufactures, sells and distributes on-board hydrogen generating and injection systems for original equipment manufacturers in the car, light truck and heavy goods vehicle markets. The company's core technology features an on-board electrolysis system that generates hydrogen and oxygen by splitting distilled water to enhance internal combustion processes, improving fuel efficiency and reducing emissions. Products target the automotive sector, including specialty industrial machinery for fuel enhancement in passenger vehicles, light trucks and heavy-duty applications. Founded in 2000 and headquartered in Pickering, Ontario, Canada, the company operates primarily from its base at 1845 Sandstone Manor, focusing on North American markets through distribution rights for OEM integration. Frank Carino serves as chief executive officer, president, treasurer, secretary and director. No major acquisitions, partnerships, funding rounds, product launches or strategic expansions have been publicly reported in the last two years as of December 2025.